| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.1 | 0.08 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.08 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.089 | 0.08 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |